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Background: Administration of mercury at nontoxic doses induces systemic autoimmune disease in Brown Norway
(BN) rats. The pathogenesis of lupus-like oral mucosal lesion by mercury-induced autoimmunity is still unclear, even
though the oral mucosa is observed to be commonly affected in mercury-treated BN rats. In this study, we
investigated the immunopathology of lupus-like oral mucosal lesions in a model of mercury-induced systemic
autoimmunity.
Methods: Brown Norway male rats were injected subcutaneously with either phosphate-buffered saline (control) or
mercury at a dose of 1.0 mg per kilogram of body weight on days 0, 3, 5, and 7. Blood, kidney, and tongue samples
were taken at various timepoints for evaluation by immunohistochemistry, RT-PCR, and lupus band test (LBT).
Results: Oral mucosal lesions were classified according to three consecutive temporal phases on the basis of
infiltration of immunocompetent cells as follows: (phase I) infiltration of MHC class II+ dendritic cells (DC) and
macrophages; (phase II) addition of ED1+ macrophage infiltrates; and (phase III) focal infiltration of pan T cells
following increased infiltration of DC and macrophages. Dense infiltration of DC and macrophages was observed in
the basement membrane (BM) zone of the oral epithelium. Tissue expression of IL-4 mRNA was detected in early
lesions (phase I), suggesting that locally produced IL-4 may be responsible for Th2-mediated immune response. A
linear and continuous smooth pattern of fluorescence was observed in the oral epithelial BM in addition to renal
glomeruli, indicating immune complex deposits.
Conclusions: Local autoimmune responses are involved in the pathogenesis of mercury-induced lupus-like lesions
of the oral mucosa.
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The etiology of autoimmune diseases remains largely un-
clear despite numerous research efforts, including clinical
studies, epidemiological studies, and those involving ex-
perimental models. Hypothetical concepts speculate that
autoimmunity results from a susceptible genetic back-
ground and the impact of specific environmental factors,
including infectious agents and chemicals/xenobiotics
[1-4]. Therefore, autoimmune diseases seem to develop
because of environmental triggers in combination with
genetic and stochastic factors.
Induction of autoimmune disease by environmental
agents, especially mercury, in susceptible rodent strains is* Correspondence: johno@college.fdcnet.ac.jp
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reproduction in any medium, provided the ora well-established and relevant model of systemic auto-
immunity [5,6]. In Brown Norway (BN) rats, repeated
administration of nontoxic doses of mercury chloride
(HgCl2) leads to T cell-dependent polyclonal activation
of B cells characterized by lymphoproliferation, hyper-
gammaglobulinemia, production of autoantibodies and
immune complex (IC) deposits in the renal glomerular
mesangium [7,8]. Target organs of systemic mercury-
induced autoimmunity include lymphoid organs, kidneys,
salivary glands, and mucocutaneous tissues [7]. Among
the mucocutaneous tissues, the oral mucosa is a target of
mercury in BN rats [7,9,10]. Histopathological findings of
mercury-induced oral mucosal lesions were characterized
by dense infiltration of mononuclear cells, including
dendritic cells (DC) and macrophages, in the lamina
propria beneath the surface epithelium of the mucosa.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Monoclonal anti-rat monoclonal antibodies used
for immunohistochemical analysis
Antibody (mAb) * Epitope Specificities
OX6 RT1B MHC class II antigens
OX19 CD5 Pan T cells
ED1 CD68 Macrophages, monocytes
*All mAbs were purchased from Cedarlane Laboratory, Burlington, ON, Canada.
Seno et al. BMC Immunology 2013, 14:47 Page 2 of 10
http://www.biomedcentral.com/1471-2172/14/47These changes seem to result from the establishment of
mercury-induced autoimmunity in the oral mucosa. How-
ever, there are few research studies of mercury-induced dis-
ease that show evidence of direct interaction between local
autoimmunity and cell infiltrates of immunocompetent
cells in the oral mucosa.
Lupus erythematosus (LE) is a chronic inflammatory
condition, considered the prototype of autoimmune hu-
man disease. Classically, LE has been subdivided into sys-
temic and cutaneous forms. Whereas systemic LE is a
multiorgan disease with variable prognoses, cutaneous LE
is a more benign condition, limited to the skin and/or mu-
cosal surfaces [11]. The prevalence of oral mucosal in-
volvement in LE patients is debatable. Some authors
suggest that oral lesions are present in 9% - 45% patient
with systemic LE and 3% -20% in those with cutaneous LE
[11]. These clinical data prompted us to examine whether
systemic autoimmunity can lead to established lupus le-
sions in the oral mucosa. In the present study, we exam-
ined oral mucosal lesions in BN rats with systemic
mercury-induced autoimmunity. First, we identified that
immunohistopathological findings are characterized by
dense infiltration of DC and macrophages in the basement
membrane (BM) zone. Second, we determined that tissue
expression of IL-4 mRNA is detected from early phase of
oral lesions. Finally, the lupus band test is positive at junc-
tion between epithelium and lamina propria. Collectively,
our data demonstrate that systemic mercury-induced
autoimmunity induces LE-like lesions in the oral mucosa.
Methods
Rats
Inbred adult male BN rats (RTln) weighing 250–350 g were
purchased from Kyudo Co. (Saga, Japan). All experiments
were performed using rats matched for strain, age, and gen-
der. Male rats were used because of their greater suscepti-
bility to mercury-induced autoimmunity [12]. The animal
experimentation protocols were approved by the Animal
Care and Use Committee of Fukuoka Dental College.
HgCl2 treatment
Groups of rats were injected with phosphate-buffered saline
(PBS) or HgCl2 (Sigma-Aldrich, St. Louis, MO, U.S.A.).
Mercury-induced autoimmunity in the BN rats has been
established by Aten et al. [7]. HgCl2, dissolved in distilled
water (1 mg/ml), was injected at a dose of 1.0 mg of mer-
cury per kilogram of body weight subcutaneously at days 0,
3, 5, and 7. At least five animals were used for each experi-
mental point. PBS-treated rats were used as controls in
all experiments.
Blood and tissue preparation
Blood samples were collected from tail veins of the mer-
cury treated and control rats at various time points. Theserum was separated and stored at −80°C for serum
autoantibody determination. Kidneys and tongues were
excised 2, 4, 6, 8, 10, 12, 14, and 21 days after injection
from the mercury-treated group (n=5 each). Control tis-
sues were collected from the control group at each time
point (n=3 each). Half of the tissue specimens were fixed
in 4% paraformaldehyde in PBS and embedded in paraf-
fin. Paraffin sections (4-μm thickness) were then stained
with hematoxylin and eosin (HE) to help visualize histo-
pathological changes. The other specimens were immedi-
ately frozen in liquid nitrogen, and serial frozen sections
were used for immunostaining, immunofluorescence (IF),
and extraction of total RNA.
Immunohistochemistry
Monoclonal antibodies (mAb) used for immunohisto-
chemistry are listed in Table 1. Acetone-fixed frozen sec-
tions were first incubated with normal rabbit serum to
decrease nonspecific binding and then reacted with
one of the mAbs. Sections were incubated with alkaline
phosphatase-conjugated anti-mouse antibody (1:150
dilution; DakoCytomation, Tokyo, Japan). Immunohis-
tochemical reactions were visualized using 5-bromo-4-
chloro-3-indolyl phosphate/nitro blue tetrazolium chloride
solution (BCIP/NBT solution; DakoCytomation). As a con-
trol, sections were treated with normal mouse IgG instead
of the first set of antibodies. Infiltrating cells in the epithelial
and subepithelial regions of the oral mucosa were counted
in 25 randomly selected areas of 50 μm2 each. Statistical
analysis was performed with the two-tailed Student’s t-test.
Data are presented as the mean ± standard error and
P values of < 0.05 were considered statistically significant.
Real-time reverse transcription-polymerase chain reaction
(qRT-PCR)
Total RNA was isolated from serial frozen sections by
acid guanidiniumthiocyanate-phenol-chloroform extrac-
tion using an ISOGEN Kit (Nippon Gene, Toyama,
Japan). One microgram of total RNA was transcribed
into cDNA using random primers, oligo (dT) primers,
and 10 μl of reverse transcriptase (ReverTra® Ace qPCR
RT Kit; Toyobo Co., Ltd., Osaka, Japan). The reverse
transcription was performed at 37°C for 15 min and then
at 98°C for 5 min. Resulting templates were subjected to
a LightCycler Nano real-time PCR system according to
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Tokyo, Japan). Predesigned primers and probe reagents
for rat interleukin-4 (IL-4), interferon-γ (IFN-γ), and
glyceraldehyde-3-phosphate dehydrogenase (G3PDH)
were commercially obtained from Roche Diagnostics.
G3PDH was used as an internal control. The relative
quantification of mRNA expression was calculated as a
ratio of IL-4 and IFN-γ genes to G3PDH. Sequences of
the primers and TaqMan probe were as follows: IL-4 for-
ward primer, 5′-CATCGGCATTTTGAACGAG-3′; re-
verse primer, 5′-CGAGCTCACTCTCTGTGGTG-3′;
Universal ProbeLibrary probe no. 2; IFN-γ forward pri-
mer, 5′-TCAAAAGAGTTCCTTATGTGCCTA-3′; re-
verse primer, 5′-TACGAGGACGGAGAGCTGTT-3′;
Universal ProbeLibrary probe no. 69; G3PDH forward
primer, 5′-AATGATCCGTTGTGGATCTGA-3′; reverse
primer, 5′-GCTTCACCACCTTCTTGATGT-3′; Univer-
sal ProbeLibrary probe no. 80. Furthermore, 1.8% agar-
ose gels were run to confirm that clean products of the
expected length had been obtained.
Detection of autoantibodies and lupus band test (LBT) by IF
Serum samples from the mercury-treated or control rats
were tested for the presence of autoantibodies by indirect
IF. Detection of antinuclear autoantibodies (ANA) was
used for HEp-2 cells as substrate [13]. Briefly, serum sam-
ples were diluted 1:50–1:1000 in PBS and were incubated
on slides with monolayer HEp-2 cells (GA Generic Assay,
Dahlewitz, Germany), followed by Alexa Flour 488-
conjugated goat anti-rat IgG Ab (Molecular Probes,
Eugene, OR, USA) diluted 1:100. Titers were expressed as
the reciprocal value of the highest serum dilution that
gave a clear positive reaction. No staining at a serum dilu-
tion of 1:50 was considered as a negative result. In situ
binding of anti-BM autoantibodies from serum samples
was tested by indirect IF using frozen sections of the kid-
neys and tongues from the control rats as substrates [14].
Serum samples diluted 1:50 up to 1:1000 were incubated
on frozen sections of kidneys and tongues. Binding sites of
serum samples were detected by Alexa Flour 488-
conjugated goat anti-rat IgG (Molecular Probes). The ti-
ters were expressed as the reciprocal value of the highest
serum dilution that gave a clear positive reaction.
LBT was performed by the direct IF method. Frozen sec-
tions of the kidneys and tongues from the mercury-treated
or control rats were incubated with FITC-conjugated
mouse anti-rat IgG, Fcγ (Jackson ImmunoResearch Labora-
tories, West Grove, PA, USA), diluted 1:10 up to 1:500.
Results
Immunohistochemical staging of mercury-induced oral
mucosal lesions by mononuclear cell infiltrates
We first analyzed infiltration of the oral mucosa from
the control and mercury-treated rats by MHC class II+,ED1+, and CD5+ cells and classified the oral mucosal le-
sions according to three consecutive phases on the basis
of density and distribution of infiltrating cells (Figures 1,
2 and 3). In this study, two different subpopulations of
macrophages were detected with monoclonal antibodies
OX 6 and ED1 [15,16]. Anti-OX 6 antibodies, which
bind to antigen-presenting cells, have been convention-
ally used to detect both DCs and macrophages in normal
and pathological tissue sections from rats. Positive DCs
in particularly are thought to function as antigen-
presenting cells. Anti-ED1 antibody is a conventional
marker for macrophages of rats and binds to a CD68-
like intracellular antigen. To compare infiltrates of the
macrophage system with those of pan T cells, the CD5
antigen, was detected with anti-OX19 antibody.
Untreated control tongues
In the tongue of the control rats, MHC class II was
expressed by Langerhans cells, DCs, and macro-
phages in the surface epithelium and lamina propria
of the oral mucosa (Figure 1A). ED1+ macrophages
were detected sparsely in the lamina propria and
submucosal tissue (Figure 1E). Only a few T cells
were observed in the lamina propria (Figure 1I). No
histological changes were seen with HE staining
(Figure 1M).
Phase I (days 4–6)
Two days after mercury administration, the number of
infiltrating cells in the tongue showed no significant dif-
ference in the mercury-treated rats compared with that
in the control rats (Figure 2). The first phase comprised
days 4–6 after the subcutaneous injection of mercury in
the rats and was characterized by an increased infiltra-
tion of MHC class II+ and ED1+ mononuclear cells
(Figures 1B and 1F, respectively). The number of cells
positive for both markers was significantly higher in the
mercury-treated rats than in the control rats (p< 0.001;
Figure 2). Furthermore, increased number of cells po-
sitive for both markers in this phase was also signifi-
cantly higher than that from mercury-treated rats by day
2 ( p< 0.05; Figure 2). The rate of increase in the number
of ED1+ cells was much less than that of MHC class II+
cells (p< 0.05; Figure 3). Most MHC class II+ cells
showed a dendritic-shape. Both MHC class II+ and ED1+
cells were mainly localized in the lamina propria beneath
the surface epithelium of the mucosa. In contrast, the
density of CD5+ T cells and the HE staining pattern in
the mercury-treated rats closely resembled that in con-
trol rats (Figures 1J and 1N). The number of T cells in
the tongue was not significantly different between the
mercury-treated rats and the control rats (Figure 2) and
it less than that of MHC class II+ DCs or ED1+ macro-
phages (p< 0.01; Figure 3).
Figure 1 Immunohistochemical staging of infiltrating mononuclear cells in the tongue of the mercury-treated rats. A-D: The tongue
specimens from the control rats show MHC class II+ cells distributed sparsely to both the lamina propria and surface epithelium (A). The number
of MHC class II+ cells increases continuously as phase progress (B-D). E-H: A few ED1+ cells are in the lamina propria of normal tongue (E).
During progression of phases, the number of ED1+ cells is increased in upper lamina propria (F-H). I-L: A small number of CD5+ T cells are
distributed in the lamina propria of tongue specimens from phases I and II as well as the control rats (I-K). In phase III specimens, focal
accumulations of CD5+ T cells are present in both the lamina propria and surface epithelium (L). M-P: No obvious changes are noted in
hematoxylin-eosin (HE)-stained tongue sections taken from thec ontrol, phase I and phase II rats (M-O). Infiltrates of mononuclear cells are
observed in the lamina propria of the oral mucosa in phase III specimens (P). Bar= 100μm.
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A phase II of oral mucosal lesions in the mercury-treated
rats at 8–10 days showed the continued increment of infil-
trates of MHC class II + and ED 1+ cells in the lamina
propria (Figures 1C and 1G, respectively). Both MHC class
II+ and ED1+ cells tended to accumulate in the BM zone.
The number of MHC class II+ and ED1+ cells increased
higher in phase II than that of those cells in phase I
(P< 0.05; Figure 2). However, the density of MHC class II+
cells was significantly high, compared with that of ED1+ cells
(P< 0.05; Figure 3). Infiltrates of T cells and tongue histology
by HE staining remained unchanged (Figures 1K and 1O).
The number of T cells in phase II showed no significant
difference, compared with that in phase I (Figures 2).
Phase III (days 12 and later)
Infiltrates of CD5+ T cells occurred during the third phase,
which started after day 12. The number of T cells was
higher (p< 0.05) in this phase than in phase II (Figure 2).Focal infiltrates of T cells were noted in the lamina propria
of the oral mucosa (Figure 1L). The continued increase in
the number of MHC class II+ and ED1+ cells remained in
this phase, showing a significant difference at p< 0.05,
compared with phase II (Figure 2). In this phase, massive
infiltration of MHC class II+ DCs showed a tendency to
attach to the surface epithelium (Figure 1D). Similarly,
ED1+ macrophages accumulated in the epithelial BM zone
of the tongue (Figure 1H). Among these infiltrating cells,
the number of MHC class II+ cells was highest, like other
phases (Figure 3). HE staining revealed cellular infiltrates
in the lamina propria of the oral mucosa, but epithelial de-
generation was not found (Figure 1P). After day 21, the
density of cell infiltrates gradually decreased.
IL-4 mRNA expression in the oral mucosa of the mercury-
treated rats
In the mercury-treated rats, a Th2-dominated autoimmune
response is induced in target organs [17]. We therefore
Figure 2 Infiltration of MHC class II+, ED1+, and OX19+ mononuclear cells in the tongue from the control rats and the mercury-treated
rats. Cells were counted from day 0 (d0) to day 21 (d21). The tongues from control rats are represented by black columns (n=3 per day), the
tongues from mercury-treated rats are indicated by white columns (n=5 per day). Cell numbers/ mm2 indicated as mean± standard error (SE).
*, significantly different at p< 0.01 compared with control. **, significantly different at p< 0.005 compared with control. There are no significant
differences in groups of white columns jointed to horizontal bars are at a p value of <0.05.
Figure 3 The number of MHC class II+, ED1+, and OX19+
mononuclear cells at various phases of oral mucosal lesions in
the mercury-treated rats. Cell numbers/ mm2 indicated as mean±
standard error (SE). *, significantly different at p< 0.01. **, significantly
different at p< 0.05.
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mRNA in the tongue during each phase of the study. qRT-
PCR analyses indicated that expression levels of mRNA en-
coding IL-4 normalized by that of G3PDH increased in
phases I and II by 2.6 fold and 2.9 fold when compared
with their control, respectively, and reached the maximum
in phase III by 8.2 fold (Figure 4A). In contrast, expression
levels of IFN-γ mRNA remained unchanged until phase II,
whereas those increased in phase III by 2.5 fold when com-
pared with the control (Figure 4B). These data from
qRT-PCR analyses were identical to those of agarose gel
electrophoresis analyses (Figure 4C).
Presence of autoantibodies in serum samples of the
mercury-treated rats
Autoimmune lesions resulting from exposure to mercury
in mice are characterized by elevated levels of serum auto-
antibodies, including ANA and antibody to glomerular ca-
pillaries in kidney [13,18]. We performed ANA detection
using HEp-2 cells. Serum samples, diluted 1:50, from the
control rats barely bound to the HEp-2 cells. These cells
Figure 4 Tissue expression of interleukin-4 (IL-4) and interferon-γ (IFN-γ) mRNA in the tongue of the mercury-treated rats by real-time
reverse transcription-polymerase chain reaction (qRT-PCR). A and B: qRT-PCR analyses examine expression levels of mRNA encoding IL-4 (A)
and IFN-γ (B) normalized by those of glyceraldehyde-3-phosphate dehydrogenase (G3PDH). Data represents mean ± standard error (SE) of
pooled data derived from three to five independent experiments. *, significantly different at p< 0.05 compared with the control. **, significantly
different at p<0.01 compared with the control. §, significantly different at p<0.05 compared with phases I and II. §§, significantly different at
p<0.05 compared with control, phases I, and II. C: Agarose gel electrophoresis analysis of qRT-PCR. Ctr, control; I, phase I; II, phase II; III, phase III.
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the mercury-treated rats by day 4. Binding of serum sam-
ples, taken from the mercury-treated rats in phase I, was
detected as combined nucleolar and nuclear cytoplasmic
fluorescence in HEp-2 cells (Figure 5A). Figure 5B shows
changes in serum titers during each phase of the study.
The serum titer was undetectable in the control rats. After
mercury-treatment, the titers increased with progression
of the lesions. The serum titer in the mercury-treated rats
was 400±67.87 in phase I , and it increased to 783.33±89.67
in phase II. In phase III, IgG ANA titer eventually reached
800±78.67. Reciprocal serum titer of IgG ANA in both
phase II and III was significantly higher than that in phase I
(p< 0.01) (Figure 5B).
We next performed indirect IF staining of frozen sec-
tions from the control rat kidney and tongue specimens
with serum samples from the mercury-treated rats to de-
termine whether those serum samples could bind to
glomerular capillaries and the BM zone of the oral mu-
cosa. Comparison of endpoint titers in indirect IF staining
were summarized in Figure 5C. Staining with serum was
absent in the kidney and tongue in control rats, showing
undetectable levels of antibodies. Similar to the ANA
assay, the titer increased during progression of lesion. The
serum titer of renal and lingual deposits was significantly
(p<0.05) higher in phases II and III compared with phase I
(Figure 5C). Serum samples from phase III rats bound
fluorescently to the glomerular capillaries and mesangium
of frozen kidney sections (Figure 5Da). Similarly, theseserum samples reacted with the epithelial BM of the
oral mucosa from the tongue of the control rats
(Figure 5Db).
LBT in kidney and tongue specimens from the mercury-
treated rats
Mercury-induced autoimmunity is also characterized by
the appearance of IC, mostly in the kidneys [19-22]. We
therefore examined kidney and tongue tissue specimens
by LBT during each phase of the study. In this study,
LBT was performed using the highest dilution (1:300) of
anti-rat IgG antibody to examine the severity of IgG de-
posits between phases in the development of mercury-
induced oral mucosal lesions. The endpoint antibody
titer was decided by preliminary experiments (data not
shown). Renal tissues from the control and phase I rats
showed no IgG deposits (Figure 6A); however, intense,
linear, continuous smooth deposits of IgG were observed
by IF in the glomerular capillary walls and mesangium
of kidneys during phases II - III in the mercury-treated
rats (Figures 6B and 6C). In the tongues from the con-
trol and phase I rats, no deposits of IgG were found
(Figure 6D). In contrast, an obvious deposition of IgG
was detected in the epithelial BM of the oral mucosa
from both phase II and III rats (Figures 6E and 6F). Re-
active IF showed a linear and continuous smooth pat-
tern. These results suggested that the severity of
immune deposits on the kidney and tongue strengthened
in phase II and III compared with phase I.
Figure 5 Antibody immunofluorescence (IF) analysis. A: Detection of antinuclear autoantibodies (ANA) by indirect IF using serum from the
mercury-treated rats with phase III lesions, incubated on HEp-2 cells. Both nucleolar and nuclear cytoplasmic fluorescences are noted. Bar=50 μm.
B: The reciprocal titer of IgG ANA in test serum samples from the rats in control and various phases. Horizontal bars denote median values.
*, significantly different at p<0.05 compared with phase I. Controls show no titers. C: The reciprocal titer of autoantibodies bound to renal capillaries
and basement membrane (BM) of the oral mucosa by indirect IF analysis. Horizontal bars denote median values. *, significantly different at p<0.05
compared with phases I. Controls show no titers. D: Indirect IF images of autoantibodies in the renal capillaries and basement membrane (BM) of
the oral mucosa using serum from Brown Norway (BN) rats with phase III lesions. (A) IF reaction of the renal capillaries and mesangium is seen in the
normal kidney. (B) IF labeling on the BM of the oral epithelium in normal tongue. Bars= 100 μm.
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In this study we used BN rats treated subcutaneously
with mercury to elucidate whether oral mucosal lesions
develop as a result of local events associated with im-
mune responses, which were similar to those in systemic
LE. Although the oral mucosa has been proposed as one
of the targets in systemic autoimmune disorders of rats
administered mercury, uncertainty remains as to whether
the pathology underlying oral mucosal lesions include
local immunological phenomena [7,9,10,23,24]. We pre-
sent three lines of evidence to support the conclusion that
local immunological events play a role in the elicitation of
lupus-like oral mucosal lesions an accompanying symp-
tom of systemic mercury-induced autoimmunity. First,
immunohistochemical approaches confirmed that an infil-
tration of both DC and macrophages occurred early dur-
ing lesion development. Second, RT-PCR results indicated
that local IL-4 release was found in the early lesions.
Third, IgG deposition was detected at the junction be-
tween the surface epithelium and lamina propria of the
oral mucosa by LBT.
The immunohistochemical results presented here indi-
cate that infiltration of DCs and macrophages occurs inthe early stage of oral lesion formation related to systemic
mercury-induced autoimmunity. These findings are sup-
ported by previous reports [9,10,24]. Because infiltration
of DCs and macrophages precedes that of T cells, we
speculate that development of oral lesions is mediated by
DCs and macrophages. Generally, increased MHC class II
antigen is most often associated with immunological stim-
uli [25]. The earliest events in which MHC class II+ cells
infiltrate around the BM zones suggest that local immune
responses related to systemic mercury-induced auto-
immunity may be established in the oral mucosa. Follow-
ing increased infiltration of MHC class II+ cells, numerous
ED1+ macrophages migrate to the BM zone, indicating
that the BM zone is the target tissue of oral mucosal le-
sions in systemic mercury-induced autoimmunity. Fur-
thermore, accumulation of macrophages can indicate
phagocytosis of injured fragments around the BM zone.
Although increased infiltration of DCs and macrophages
is not a primary event in mercury-induced autoimmunity,
it may play an important secondary role in the pathogen-
esis of this syndrome. In contrast to the predominance of
DC/macrophage-infiltration, participation of T cells seem
to be less important in oral lesions. These findings suggest
Figure 6 Lupus band test (LBT) with FITC-conjugated anti-rat IgG, Fcγ, antibody (1:300) incubated on frozen sections of the kidneys
and tongues from mercury-treated rats. A-C: No immunofluorescence (IF) staining is seen in phase I (A). IF reaction on the glomerular
mesangial regions during phases II (B) and III (C). D-F: A very weak or faint reaction is seen in the portion of the basement membrane (BM) of
the oral epithelium of the tongue by phase I (D). Remarkable IF appears on the BM of the epithelium of the tongue in phases II (E) and III (F).
Bar= 100 μm.
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against local immune responses around the BM zone.
RT-PCR showed that tissue expression of IL-4 mRNA
was observed from the early phase of oral lesions,
suggesting that a local Th2-mediated immune response
is responsible for the development of mercury-induced
oral mucosal lesions. Previous RT-PCR analyses of
mercury-treated BN rats show upregulation of IL-4
mRNA [26,27]. These reports speculate that IL-4 may
serve multiple roles in the development of lupus. Phase I
specimens were found to express IL-4 mRNA by RT-
PCR, along with immunohistochemically detected infil-
tration of DC and macrophages in the absence of T cells.
These findings suggest that cells other than T cells may
be associated with IL-4 synthesis, even though T cells
are known to participate in the secretion of this cytokine
[28,29]. Although our immunohistochemical results
reported here do not identify the type (s) of cells ex-
pressing IL-4 mRNA, a previous study demonstrated
that mercury induced upregulation of IL-4 mRNA ex-
pression in mast cells of BN rats [27]. Future work will
address the origin of cells bearing IL-4 mRNA in
mercury-induced oral mucosal lesions.
The observation of upregulated expression of IFN-γ
mRNA in phase III specimens was unexpected. IFN-γ
is generally responsible for the development of Th1-
mediated immune responses, such as graft-versus-host
disease. Our previous report examined IFN-γ induced
epithelial expression of intercellular adhesion-1 (ICAM-
1) in the early phase of oral mucosal graft-versus-host
disease [30]. It is difficult to explain why IFN-γ expres-
sion is upregulated in the late stage of mercury-induced
oral mucosal lesions. Mercury-induced autoimmunity in
BN rats is generally characterized by its weak symptoms,most of which resolve by 20 days after onset [31]. A
speculative possibility is that a Th2-mediated immune
response responsible for the development of mercury-
induced oral lesions may be decreased by the predomin-
ant Th1-mediated immune response in the late stage.
IF analyses indicate that the oral mucosa is one of the
targets in mercury-induced systemic autoimmunity in BN
rats. According to autoantibody production results and a
positive LBT reaction in renal glomeruli, we support the
mercury-treated BN rats as a model for the development
of a systemic lupus-like syndrome. These findings are in
concordance with data from other research groups, which
showed that the features of mercury-induced autoimmun-
ity in rats and mice, including lymphadenopathy, hy-
pergammaglobulinemia, humoral autoimmunity, and IC
deposits, are consistent with the autoimmunity observed
in systemic LE [21,32-34]. In this study, serum samples
from the mercury-treated BN rats contained autoanti-
bodies, such as ANA and anti-BM antibody. It is known
that ANAs could signal the body to begin attacking itself,
which can lead to autoimmune diseases, including lupus,
scleroderma, Sjögren’s syndrome, drug-induced lupus, and
autoimmune hepatitis [35,36]. Indirect IF, using serum
samples from the mercury-treated rats, showed a linear
reaction in the renal glomeruli. Similarly, LBT of the
kidney in the mercury-treated rats revealed a linear IF re-
action in the glomeruli. LBT can be used to confirm IC-
mediated reactions. Both indirect and direct IF studies
demonstrated the deposition of glomerular IC in mercury-
treated rat kidneys. Glomerular IC deposits are a hallmark
of lupus-like autoimmune disease [22]. In the tongue of
the mercury-treated rats, LBT, as well as indirect IF assays,
showed the linear deposition of IC in the BM zone, similar
to the findings in the kidney. This suggests that the oral
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On the basis of these results, we suggest that the lupus-
like oral mucosal lesions from mercury-induced systemic
autoimmunity, are initiated by the deposition of IC in BM,
followed by infiltration of DCs and macrophages into the
IC deposition.
In summary, these results provide additional support for
the characterization of oral mucosal lesions, in mercury-
induced autoimmune disease. The IC deposits in BM are
undoubtedly a key step in the pathogenesis of lupus-like
oral mucosal lesions.
Conclusions
Mercury-induced systemic autoimmune responses in-
duce lupus-like lesions in the oral mucosa.
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